Visceral leishmaniosis in HIV-positive patients: Primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts

AIDS

Volumn 12, Issue 16, 1998, Pages 2147-2153

  Kubar, Joanna ^a   Marty, Pierre ^a   Lelièvre, Alain ^a   Quaranta, Jean François ^a   Staccini, Pascal ^b   Caroli Bosc, Corinne ^c   Le Fichoux, Yves ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b Hôpital Saint Roch Nice   (France)

^c INSERM   (France)

Author keywords

Antileishmanial antibodies; CD4; Immunosuppression; Latency; Leishmania persistence; Natural history progression; Opportunistic infection; Parasitology

Indexed keywords

CD4 ANTIGEN; PROTOZOON ANTIBODY;

ADULT; ARTICLE; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; LEISHMANIA INFANTUM; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OPPORTUNISTIC INFECTION; PRIMARY INFECTION; PRIORITY JOURNAL; SEROLOGY; T LYMPHOCYTE; VISCERAL LEISHMANIASIS;

ACUTE DISEASE; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED;

EID: 0032512075     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199816000-00009     Document Type: Article

References (42)

1. Pearson RD, de Queiroz Souza A: Clinical spectrum of leishmaniasis. Clin Infect Dis 1995, 22:1-13.
2. Reed SG, Scott P: T-cell and cytokine responses in leishmaniasis. Curr Opin Immunol 1993, 5:524-531.
3. Jankovic D, Sher A: Initiation and regulation of CD4+ T-cell function in host-parasite models. In Th1 and Th2 cells in Health and Disease. Edited by Romagnani S. Chem Immunol 1996, 63:51-65.
4. Reiner SL, Locksley RM: The regulation of immunity to Leishmania major. Annu Rev Immunol 1995, 13:151-177.
5. Murray HW, Squires KE, Miralles CD, et al.: Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokines roles in initial versus established immunity. J Immunol 1992, 148:1858-1863.
6. Green SJ, Melzer MS, Hibbs Jr JB, Nacy CA: Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine dependent killing mechanism. J Immunol 1990, 144:1278-1285.
7. Stenger S, Donhauser N, Thüring H, Röllinghoff M, Bogdan C: Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Virol 1996, 183:1501-1515.
8. Evans TG, Reed SS, Hibbs Jr JB: Nitric oxide production in murine leishmaniasis: Correlation of progressive infection with increasing systemic synthesis of nitric oxide. Am J Trop Med Hyg 1996, 54:486-489.
9. Bories C, Scherman E, Bories PN: Serum and tissue nitrate levels in murine visceral leishmaniasis correlate with parasite load but not with host protection. Trans R Soc Trop Med Hyg 1997, 91:433-436.
10. de Rossell RA, de Jesus de Duran R, Rossell O, Rodrigez AM: Is leishmaniasis ever cured? Trans R Soc Trop Med Hyg 1992, 86:251-253.
11. Aebisher T: Recurrent cutaneous leishmaniasis: a role for persistent parasites. Parasitol Today 1994, 10:25-28.
12. Moll H, Flohè S, Röllinghoff M: Dentritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur J Immunol 1995, 25:693-699.
13. Albrecht H, Sobottka I, Emminger C, et al.: Visceral Leishmaniasis emerging as an important opportunistic infection in HIV-infected persons living in areas nonendemic for Leishmania donovani. Arch Pathol Lab Med 1996, 120:189-198.
14. Alvar J, Canavate C, Gutierrez-Solar B, et al.: Leishmania and Human Immunodeficiency Virus coinfection: the first 10 years. Clin Microbiol Rev 1997, 10:298-319.
15. Ma DDF, Concannon AJ, Hayes J: Fatal leishmaniasis in renal transplant patient. Lancet 1979, 2:311-312.
16. Abdeladhim A, Ben Salem N, Gastli M, Boussen M: Mediterranean visceral leishmaniasis associated with chronic myeloid leukemia. Tunis Med 1986, 64:491-492.
17. Aguado JM, Gomez Berne J, Figuera A, de Villalobos E, Fernandez-Guerrero ML, Sanchez Fayos J: Visceral leishmaniasis (kala-azar) complicating acute leukemia. J Infect 1983, 7:272-274.
18. Di Cataldo A, Lo Nigro L, Marino S, Schiliro G: Visceral leishmaniasis in three children with leukemia. Pediatr Infect Dis J 1996, 15:916-918.
19. Marty P, Lelièvre A, Quaranta JF, Rahal A, Gari-Toussaint M, Le Fichoux Y: Use of the leishmanin skin test and western blot analysis for epidemiological studies in visceral leishmaniasis areas: experience in a highly endemic focus in Alpes-Maritimes (France). Trans R Soc Trop Med Hyg 1994, 88:658-659.
20. Suffia I, Quaranta JF, Eulalio MCM, et al.: Human T-cell activation by 14- and 18-kilodalton nuclear proteins of Leishmania infantum. Infect Imumun 1995, 63:3765-3771.
21. Kubar J, Quaranta JF, Aufeuvre JP, Marty P, Lelièvre A, Le Fichoux Y: Transmission of Leishmania infantum by blood donors. Nature Med 1997, 3:368.
22. Marty P, Lelier̀ve A, Quaranta JF, et al.: Detection by Western blot of four antigens characterizing acute clinical leishmaniasis due to Leishmania infantum. Trans R Soc Trop Med Hyg 1995, 98:690-691.
23. Izri MA, Deniau M, Briere C, et al.: Leishmaniasis in AIDS patients: results of leukocytoconcentration, a fast biological method of diagnosis. Bull WHO 1996, 74:91-93.
24. Mayer L, Magierowska M, Hubert JB, et al.: Early protective effect of CCR-5 D32 heterozygosity on HIV-1 disease progression: relationship with viral load. AIDS 1997, 11:F73-F78.
25. Condom MJ, Clotet B, Sirera G, Milla F, Foz M: Asymptomatic leishmaniasis in the acquired immunodeficiency syndrome. Ann Intern Med 1989, 11:767-768.
26. World Health Organization. Report on the consultative meeting on Leishmania/HIV coinfection. WHO/LEISH/95.35. Geneva, Switzerland: World Health Organization; 1995:1-14.
27. Alvar J: Leishmaniasis and AIDS coinfection. The Spanish example. Parasitol Today 1994, 10:160-163.
28. Gramiccia M, Gradoni L, Troiani M: HIV-Leishmania coinfections in Italy. Isoenzyme characterization if Leishmania causing visceral laishmaniasis in HIV patients. Trans R Soc Trop Med Hyg 1992, 86:161-163.
29. Marty P, Le Fichoux Y, Pratlong F, Gari-Toussaint M: Human visceral leishmaniasis in Alpes-Maritimes, France: epidemiological characteristics for the period 1985-1992. Trans R Soc Trop Med Hyg 1994, 88:33-34.
30. Badaro R, Jones TC, Lorenco R, et al.: A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 1986, 154:639-649.
31. Alvar J, Gutiérrez-Solar B, Molina R, et al.: Prevalence of Leishmania infection among AIDS patients. Lancet 1992, 339:1427.
32. Bissuel F, Leport C, Perronne C, Longuet P, Vilde JL: Fever of unknown origin in HIV-infected patients: a critical analysis of a retrospective series of 57 cases. J Intern Med 1994, 236:529-535
33. Miralles P, Moreno S, Pérez-Tascon M, Cosin J, Diaz MD, Bouza E: Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis 1995, 20:872-875.
34. Pineda JA, Hernandez-Quero J, Gallardo JA, et al.: Frequency of subclinical visceral leishmaniasis in HIV-1 infected patients in Spain. Eur J Clin Microbiol Infect Dis 1996, 15:263-264.
35. Gradoni L, Scalone A, Gramiccia M: HIV-Leishmania coinfections in Italy: serological data as indication of the sequence of acquisition of the two infections. Trans R Soc Trop Med Hyg 1993, 87:94-96.
36. Berhe N, Hailu A, Wolday D, Negesse Y, Cenini P, Frommel D: Ethiopian visceral leishmaniasis patients coinfected with human immunodeficiency virus. Trans R Soc Med Hyg 1995, 89:205-207.
37. Mondain-Miton V, Toussaint-Gari M, Hofman P, et al.: Atypical leishmaniasis in a patient infected with human immunodeficiency virus. Clin Infect Dis 1995, 21:663-665
38. Gradoni L: Chemotherapy of leishmaniasis and trypanosomiasis. Curr Opin Infect Dis 1996, 9:435-438.
39. Shankar AH, Titus RG: T cell and non-T cell compartements can independently determine resistance to Leishmania major. J Exp Med 1995, 181:845-855.
40. Rousseau D, Suffia I, Ferrua B, Philip P, Le Fichoux Y, Kubar J: Prolonged administration of dexamethasone induces limited reactivation of visceral leishmaniosis in chronically infected BALB/c mice. Eur Cytokine Netw (in press)
41. Abramo C, Fontes CJ, Krettli AU: Cross-reactivity between antibodies in the sera of individuals with leishmaniasis, toxoplasmosis, and Chagas' disease and antigens of the blood-stage forms of Plasmodium falciparum determined by indirect immunofluorescence. Am J Trop Med Hyg 1995, 53:202-205.
42. Mosier DE: Consequences of secondary or co-infections for immunity. Curr Opin Immunol 1993, 6:539-544.